We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
+4.51%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$912M
AUM Growth
+$112M
(+14%)
Cap. Flow
+$107M
Cap. Flow
% of AUM
11.78%
Top 10 Holdings %
Top 10 Hldgs %
35.88%
Holding
80
New
13
Increased
28
Reduced
21
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXAS
Exact Sciences
EXAS
|
+$18.6M |
| 2 |
ARRY
Array Biopharma Inc
ARRY
|
+$16.5M |
| 3 |
Gilead Sciences
GILD
|
+$16.3M |
| 4 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$13.4M |
| 5 |
ALDR
Alder Biopharmaceuticals
ALDR
|
+$12.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLRN
Acceleron Pharma
XLRN
|
+$20.7M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$14.8M |
| 3 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$14.2M |
| 4 |
LOXO
Loxo Oncology, Inc
LOXO
|
+$12.8M |
| 5 |
Acadia Pharmaceuticals
ACAD
|
+$9.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 91.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WMGI
51
DELISTED
Wright Medical Group Inc
WMGI
| $6.1M | 0.67% |
307,672
-300
| -0.1% | -$6.43K |
|
52
Evolent Health
EVH
$371M
| $6.04M | 0.66% |
423,482
-68,500
| -14% | -$981K |
|
53
Madrigal Pharmaceuticals
MDGL
$12.6B
| $5.92M | 0.65% |
50,649
+13,799
| +37% | +$1.7M |
|
|
ALBO
54
DELISTED
Albireo Pharma Inc
ALBO
| $5.63M | 0.62% |
172,803
-70,000
| -29% | -$2.36M |
|
|
SAGE
55
DELISTED
Sage Therapeutics
SAGE
| $5.25M | 0.58% |
32,600
+15,400
| +90% | +$2.61M |
|
|
MNTA
56
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $4.8M | 0.53% |
264,699
-235,599
| -47% | -$3.93M |
|
57
Q32 Bio
QTTB
$435M
| $4.21M | 0.46% |
+12,500
| New | +$4.2M |
|
58
Rocket Pharmaceuticals
RCKT
$343M
| $4.05M | 0.44% |
+216,158
| New | +$3.52M |
|
|
OBSV
59
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $3.91M | 0.43% |
289,507
+78,100
| +37% | +$958K |
|
60
Indaptus Therapeutics
INDP
$243M
| $2.85M | 0.31% |
201
+43
| +27% | +$609K |
|
|
AVXS
61
DELISTED
AveXis, Inc. Common Stock
AVXS
| $2.73M | 0.3% |
+22,120
| New | +$2.63M |
|
62
Savara
SVRA
$1.08B
| $2.51M | 0.28% |
273,000
+113,000
| +71% | +$1.33M |
|
|
FSTX
63
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $2.02M | 0.22% |
32,914
+2,068
| +7% | +$109K |
|
64
Accuray
ARAY
$27.5M
| $1.92M | 0.21% |
384,547
-210,900
| -35% | -$1.11M |
|
|
CMTA
65
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
| $1.7M | 0.19% |
112,213
+36,900
| +49% | +$600K |
|
66
Zai Lab
ZLAB
$2.07B
| $1.06M | 0.12% |
49,584
| – | – |
|
67
Dr. Reddy's Laboratories
RDY
$9.8B
| $833K | 0.09% |
127,480
| – | – |
|
|
SRRA
68
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $417K | 0.05% |
5,042
| – | – |
|
69
AbbVie
ABBV
$465B
| – | – |
-85,298
| Closed | -$8.25M |
|
70
Acadia Healthcare
ACHC
$2.55B
| – | – |
-126,602
| Closed | -$4.13M |
|
71
Agios Pharmaceuticals
AGIO
$2.08B
| – | – |
-47,799
| Closed | -$2.73M |
|
|
DBVT
72
DBV Technologies
DBVT
$813M
| – | – |
-6,030
| Closed | -$1.48M |
|
73
Insmed
INSM
$22.4B
| – | – |
-90,199
| Closed | -$2.81M |
|
74
Merck
MRK
$322B
| – | – |
-113,709
| Closed | -$6.11M |
|
75
Puma Biotechnology
PBYI
$398M
| – | – |
-15,050
| Closed | -$1.49M |
|
Similar funds
RIP
LFWA
CF
WIM
MW
AFC
AAA
TGM
Sectoral Asset Management's Q1 2018 Portfolio in Review
As of Q1 2018, Sectoral Asset Management held 80 positions worth $912M, up 14% from $800M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Sectoral Asset Management deployed $107M of net new capital in Q1 2018, opening 13 new positions and adding to 28 existing holdings. Its largest new stake was Array Biopharma Inc: 1,031,650 shares worth $16.8M.
By sector, the portfolio is most concentrated in Healthcare at 91% of assets, down from 92% a quarter earlier.
On the sell side, the largest reduction was Acceleron Pharma, an estimated $20.7M trimmed.
- Sectoral Asset Management's largest Q1 2018 buy was Array Biopharma Inc: 1,031,650 shares worth $16.8M.
- Sectoral Asset Management added most to Exact Sciences in Q1 2018, an estimated $18.6M increase.
- Sectoral Asset Management's biggest Q1 2018 reduction was Acceleron Pharma, cutting an estimated $20.7M.
- Sectoral Asset Management fully exited Regeneron Pharmaceuticals in Q1 2018, selling an estimated $14.8M.
- Sectoral Asset Management's ten largest holdings make up 36% of its $912M portfolio in Q1 2018.
- Sectoral Asset Management opened 13 new positions and closed 12 in Q1 2018.
- Sectoral Asset Management's portfolio value rose 14% quarter-over-quarter to $912M.
Based on Sectoral Asset Management's 13F filing for Q1 2018, filed 15 May 2018.